Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
In order to utilize polygenic risk scores (PRSs) for Alzheimer’s disease (AD) in a meaningful way, influential factors (i.e. training set) and prediction across groups such as APOE e4 (APOE4) genotype as well as associations to dementia-related biomarkers should be explored. Therefore, we examined t...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 July 2023
|
| In: |
Alzheimer's research & therapy
Year: 2023, Volume: 15, Pages: 1-9 |
| ISSN: | 1758-9193 |
| DOI: | 10.1186/s13195-023-01277-8 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13195-023-01277-8 Verlag, kostenfrei, Volltext: https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01277-8 |
| Author Notes: | Hannah Stocker, Kira Trares, Léon Beyer, Laura Perna, Dan Rujescu, Bernd Holleczek, Konrad Beyreuther, Klaus Gerwert, Ben Schöttker and Hermann Brenner |
| Summary: | In order to utilize polygenic risk scores (PRSs) for Alzheimer’s disease (AD) in a meaningful way, influential factors (i.e. training set) and prediction across groups such as APOE e4 (APOE4) genotype as well as associations to dementia-related biomarkers should be explored. Therefore, we examined the association of APOE4 and various PRSs, based on training sets that utilized differing AD definitions, with incident AD and all-cause dementia (ACD) within 17 years, and with levels of phosphorylated tau181 (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) in blood. Secondarily, effect modification by APOE4 status and sex was examined. |
|---|---|
| Item Description: | Gesehen am 07.12.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1758-9193 |
| DOI: | 10.1186/s13195-023-01277-8 |